Prof. Enrico Lopriore joins JCTR clinical editorial board
August 30, 2022
Enrico Lopriore is a professor of neonatology and fetal medicine and head of the Neonatal Intensive Care Unit at the Leiden University Medical Center (LUMC), The Netherlands.
The research from Enrico Lopriore focuses mainly on the origin, management and outcome in various fetal disorders, including complicated monochorionic twins (with TTS, TAPS or sIUGR) and fetal hematologic diseases (anemia or thrombocytopenia). The ultimate goal of his research is to improve perinatal survival and in particular the long-term outcome in these vulnerable babies.
Enrico Lopriore absolved Medical School and his doctoral research at Leiden University. He was appointed Professor in Neonatology of the Leiden University Medical Center in July 2016. Enrico's publication record can be found .
Dr. Ibrahim Ince joins JCTR clinical editorial board
August 9, 2022
Ibrahim Ince studied Bio-pharmaceutical sciences in Leiden, the Netherlands, and obtained his PhD in the field of Pharmacology and Pharmacometrics at the Erasmus Medical Center - Sophia Children's Hospital in Rotterdam, the Netherlands. Since 2014 he is working as expert in systems pharmacology and medicine, and as pharmacometrics leader at the pharmacometrics department at Bayer AG, Germany. Ibrahim is involved in physiology-based pharmacokinetics (PBPK) in silico modeling and simulation in several clinical drug development projects within Bayer AG in the field of cardiovascular diseases, infectious diseases and to a lesser extend oncology. He is particularly specialized in model based extrapolation to special populations such as pediatrics, renal- and hepatic impaired patient populations. Ibrahim's publication record can be found .
Dr. Frank Schaap promoted to associate editor
July 29, 2022
Frank Schaap studied biochemistry and molecular biology, and obtained his PhD in the field of cardiac physiology. Working as a postdoc at the department of Experimental Hepatology (AMC, Amsterdam) and the Tytgat Institute for Liver and Intestinal Research (Amsterdam), he became fascinated by the biology and endocrine actions of bile salts. He is appointed at the Department of Surgery at the university hospitals in Maastricht, The Netherlands, and Aachen, Germany. His team studies the role of the gut-liver bile salt signaling axis in intestinal and liver health and disease, and his research has a translational character, employing the (surgical) patient with perturbed enterohepatic circulation as a 'model'. Frank's publication record can be found .
Special issue on regenerative medicine in head and neck
July 27, 2022
JCTR is organizing a special issue with Guest Editor, Prof. Petros D. Karkos, on regenerative medicine in head and neck: clinical and basic science perspectives. The submission deadline is October 31, 2023.
Prof. Karkos is an associate professor in otolaryngology at Aristotle University of Thessaloniki in Greece. Find more information about this special issue .
JCTR welcomes Prof. Joshua A. Jackman
July 26, 2022
Prof. Joshua A. Jackman joins of JCTR. Prof. Joshua A. Jackman is an assistant professor in the School of chemical engineering and biomedical institute for convergence at Sungkyunkwan University (SKKU) in South Korea. He is also the director of the translational nanobioscience research center at SKKU.
JCTR will adopt article processing charges per August 1st, 2022 (9 am CET)
July 14, 2022
Since its inauguration in 2015, JCTR operations have been funded by the publisher and editorial team throughout its seven-year existence. During this period, we have expanded the journal's support network and built value for contributors. The journal is poised to reach the final major milestone, which is indexation by the Web of Science database and, in due course, receiving an impact factor. To cover the reorganization at the publisher and costs related to the publishing process, JCTR will adopt an article processing charge (APC) of USD 1000 for the publication of an accepted article submitted on or after August 1, 2022 (starting 9 am CET). Upon acceptance of a manuscript, authors will be asked to pay the APC, which will release their manuscript for publication.
APC discounts and waivers
We encourage authors to publish their papers with JCTR and do not wish the APC cost to become a barrier, especially to authors based in the low-income or lower middle-income countries/regions as defined by the World Bank. Authors from these countries/regions are encouraged to use the discount rate/waiver offered by the publisher.